![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
B Ault and JV Nadler
The effects of baclofen, an antispastic drug, on excitatory transmission were tested by bath application to the hippocampal slice preparation. (+/-)-Baclofen (20 microM) strongly depressed extracellularly recorded synaptic responses to stimulation of projections that originate from CA3 hippocampal pyramidal cells. Responses to stimulation of four other excitatory pathways were little affected and the amplitudes of presynaptic fiber potentials and antidromic responses were unaltered. When tested on the Schaffer collateral-commissural-CA1 pyramidal cell synapse. (-)-baclofen depressed the amplitude of the extracellular excitatory postsynaptic potential with an IC50 of 3.7 microM and was 180 times more potent than (+)-baclofen. gamma-Aminobutyric acid, 3-aminopropanesulfonic acid and imidazole-4-acetic acid also inhibited transmission at this site. Baclofen could suppress the response completely, and its action was unaffected by bicuculline. In contrast, imidazole-4-acetic acid could suppress the response by a maximum of only 75%, and its action was highly sensitive to bicuculline. gamma-Aminobutyric acid and 3- aminopropanesulfonic acid could suppress the response completely, and their actions were relatively weakly antagonized by bicuculline. These results are consistent with the hypothesis that baclofen inhibits excitatory transmission by interacting with a bicuculline-insensitive gamma-aminobutyric acid receptor. These receptors may be located on one type of glutamatergic/aspartergic synaptic terminal, exemplified by axon terminals of CA3 hippocampal pyramidal cells. Synapses made by these axons may therefore serve as models for studying the mechanism of action of baclofen.
This article has been cited by other articles:
|
|
 |
|
  C. J. Price, R. Scott, D. A. Rusakov, and M. Capogna GABAB Receptor Modulation of Feedforward Inhibition through Hippocampal Neurogliaform Cells J. Neurosci., July 2, 2008; 28(27): 6974 - 6982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sizemore and D. J. Perkel Noradrenergic and GABAB Receptor Activation Differentially Modulate Inputs to the Premotor Nucleus RA in Zebra Finches J Neurophysiol, July 1, 2008; 100(1): 8 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Speed and L. E. Dobrunz Developmental Decrease in Short-Term Facilitation at Schaffer Collateral Synapses in Hippocampus Is mGluR1 Sensitive J Neurophysiol, February 1, 2008; 99(2): 799 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Gipson and M. F. Yeckel Coincident Glutamatergic and Cholinergic Inputs Transiently Depress Glutamate Release at Rat Schaffer Collateral Synapses J Neurophysiol, June 1, 2007; 97(6): 4108 - 4119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Otmakhova and J. E. Lisman Contribution of Ih and GABAB to Synaptically Induced Afterhyperpolarizations in CA1: A Brake on the NMDA Response J Neurophysiol, October 1, 2004; 92(4): 2027 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Molyneaux and M. E. Hasselmo GABAB Presynaptic Inhibition Has an In Vivo Time Constant Sufficiently Rapid to Allow Modulation at Theta Frequency J Neurophysiol, March 1, 2002; 87(3): 1196 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Hasselmo and B. P. Fehlau Differences in Time Course of ACh and GABA Modulation of Excitatory Synaptic Potentials in Slices of Rat Hippocampus J Neurophysiol, October 1, 2001; 86(4): 1792 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kali and P. Dayan The Involvement of Recurrent Connections in Area CA3 in Establishing the Properties of Place Fields: a Model J. Neurosci., October 1, 2000; 20(19): 7463 - 7477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shew, S. Yip, and B. R. Sastry Mechanisms Involved in Tetanus-Induced Potentiation of Fast IPSCs in Rat Hippocampal CA1 Neurons J Neurophysiol, June 1, 2000; 83(6): 3388 - 3401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Otmakhova and J. E. Lisman Dopamine Selectively Inhibits the Direct Cortical Pathway to the CA1 Hippocampal Region J. Neurosci., February 15, 1999; 19(4): 1437 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. V. Wallenstein and M. E. Hasselmo GABAergic Modulation of Hippocampal Population Activity: Sequence Learning, Place Field Development, and the Phase Precession Effect J Neurophysiol, July 1, 1997; 78(1): 393 - 408. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
